Clinical Trials Logo

Behavioural Disturbances clinical trials

View clinical trials related to Behavioural Disturbances.

Filter by:
  • None
  • Page 1

NCT ID: NCT01608217 Completed - Pain Clinical Trials

Delta-THC in Dementia

Start date: June 2012
Phase: Phase 2
Study type: Interventional

This is a phase II, randomized, placebo-controlled, double-blind, parallel-group, multicentre study to the efficacy and safety of low dose delta-9-THC in behavioural disturbances and pain in patients with mild to severe dementia, when added to an analgesic treatment with acetaminophen. It is hypothesized that Namisol® will lead to more behavioural disturbances than placebo, when added to an analgesic treatment with acetaminophen, and as measured by a change in Neuropsychiatric Inventory (NPI) score, after a three week treatment period. It is expected that this will be due, primarily, to psychoactive effects of Namisol® and secondary to a reduction in pain sensation (as measured with VRS and PACSLAC-D). It is expected that a reduction in NPS will positively affect quality of life and lead to better functioning in daily living.